Lithium: Clinical Trials

121 trials of Lithium, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

81 completed, 13 unknown, 12 terminated, 7 recruiting. 45 Phase 4, 26 Phase 3, 19 Phase 2, 16 Not applicable, 16 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 445Completed 27, Unknown 9, Terminated 4, Withdrawn 3, Active not recruiting 1, Recruiting 1
Phase 326Completed 19, Terminated 4, Recruiting 3
Phase 219Completed 13, Withdrawn 2, Active not recruiting 1, Recruiting 1, Terminated 1, Unknown 1
Not applicable16Completed 13, Terminated 2, Unknown 1
Phase 116Completed 12, Terminated 2, Active not recruiting 1, Withdrawn 1
Early Phase 11Unknown 1

Follow Lithium: new trials by email Literature Review of Lithium trials Research Report on Lithium

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Assess the Long-term Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-3)
KarXT, Lithium, Valproate - Bipolar Disorder Type I With Mania
Phase 3RecruitingBristol-Myers Squibb4502025-07-182026-09-14
Real-world Lithium Intake
Lithium (LI) based on clinical indication - Bipolar Disorder (BD)
RecruitingUniversity of Aarhus502025-07-052025-09-11
Τhe Combination of Pharmacotherapy With RECOVERYTRSGR and RECOVERYTRSBDGR.
Group A: (Clozapine, quietiapine, olanzapine, aripiprazole, zyprasidone, risperidone, asenapine, paliperidone, clopixol,anxiolytics: clonazepam, stedon, tavor antidepressants: seropram),, Group B (Pharmacotherapy and TAU) (Clozapine, quietiapine, olanzapine, aripiprazole, zyprasidone, risperidone, asenapine, paliperidone, clopixol, clonazepam, stedon, tavor, antidepressants,, Group C (Pharmacotherapy and Psychotherapy) Clozapine, quietiapine, olanzapine, aripiprazole, zyprasidone, risperidone, asenapine, paliperidone, clopixol, clonazepam, stedon, tavor, lithium, depakine - Treatment Resistant Schizophrenia, Treatment Resistant Bipolar Disorder
Phase 4Active not recruitingDr. Stavroula Rakitzi842025-06-042026-05-01
Intensified Pharmacological Treatment for Schizophrenia, Major Depressive Disorder and Bipolar Depression After a First-time Treatment Failure
Clozapine, Esketamine Nasal Product, Escitalopram - Schizophrenia and Related Disorders, Major Depressive Disorder
Phase 3RecruitingDr. Inge Winter12542025-04-272026-01-22
The Effect of a Six Week Intensified Pharmacological Treatment for Bipolar Depression Compared to Treatment as Usual in Subjects Who Had a First-time Treatment Failure on Their First-line Treatment.
Escitalopram, Sertraline, Venlafaxine - Bipolar Depression
Phase 3RecruitingDr. Inge Winter4182025-02-112025-09-26
A Study of Lithium and Enlicitide in Healthy Adult Participants (MK-0616-034)
lithium carbonate, enlicitide - Healthy
Phase 1CompletedMerck Sharp & Dohme LLC162025-01-022025-02-17
A Study to Evaluate the Effects of Lithium, Valproic Acid, and Lamotrigine on the Pharmacokinetics of KarXT and Effects of KarXT on the Pharmacokinetics of Lithium, Valproic Acid, and Lamotrigine in Healthy Participants
Xanomeline/Trospium Chloride, Lithium, Valproic Acid - Healthy Volunteers
Phase 1CompletedKaruna Therapeutics, Inc., a Bristol Myers Squibb company1332024-12-262026-02-24
Repurposing Lithium for Parkinson's Disease: a RCT
Lithium, Placebo - Parkinson Disease
Phase 1 / Phase 2Active not recruitingState University of New York at Buffalo202024-07-032026-06-16
Lithium Treatment to Prevent Cognitive Impairment After Brain Radiotherapy
Lithium, Placebo - Cognitive Impairment, Cognitive Decline
Phase 2RecruitingRegion Stockholm842024-02-162024-04-12
Lithium Long COVID Dose-finding Study
Lithium - Long COVID
Phase 1CompletedState University of New York at Buffalo52023-10-122024-10-22
Electroconvulsive Therapy and Concomitant Lithium in Depressive Disorder: A Pilot Study
Lithium - Depressive Disorder
Early Phase 1UnknownMelbourne Health202023-06-012023-08-01
Lithium Versus Cariprazine in the Acute Phase Treatment of Bipolar Depression (DUAG9)
Lithium, Cariprazine - Depression, Bipolar
Phase 4RecruitingAalborg University Hospital1222022-12-132026-01-21
Effect of Lithium Therapy on Long COVID Symptoms
Lithium, Placebo - Long COVID
Phase 2CompletedState University of New York at Buffalo522022-11-282025-03-05
Lithium Versus Anticonvulsants and the Risk of Physical Disorders
Lithium - Bipolar Disorder
CompletedMental Health Centre Copenhagen, Bispebjerg and Frederiksberg Hospital1692852022-06-012023-08-22
Dose Escalation Study of Lithium With Oxaliplatin and Capecitabine in Advanced Oesophago-Gastric or Colorectal Cancer
Lithium, Oxaliplatin, Capecitabine - Colorectal Neoplasms, Stomach Neoplasm
Phase 1TerminatedCancer Trials Ireland22022-01-132025-07-08
Indirect Evaluation of Lithium Level in Blood Using Non-invasive Sweat Biosensors
Smartwatch with integrated Li+ sensor (provided by Spectrophon LTD) - Lithium Level Detection in Sweat
UnknownTirat Carmel Mental Health Center752020-01-012020-10-08
Effects of Lithium Therapy on Blood-based Therapeutic Targets in Parkinson's Disease.
Lithium - Parkinson Disease
Phase 1CompletedState University of New York at Buffalo192019-10-172023-08-15
Preventing Relapse After Successful Electroconvulsive Therapy for Depression
Lithium - Major Depressive Disorder (MDD)
Not applicableCompletedUniversiteit Antwerpen962019-07-262026-05-05
Lithium Effects on the Brain's Functional and Structural Connectome in the Treatment of Bipolar Disorder
Lithium - Bipolar Disorder, Bipolar I Depression
CompletedBrigham and Women's Hospital812017-12-072026-07-16
Effect of Lithium Versus Placebo in Adults With Treatment-Resistant Depression Who Are Receiving Ketamine
Lithium, Placebo, Ketamine - Treatment Resistant Depression
Phase 2WithdrawnWilliam V. Bobo, M.D.2017-11-302018-08-16

Showing 20 of 121. Sign in to see all of them.

Conditions studied

Bipolar Disorder (64)  ·  Depression (23)  ·  Depressive Disorder, Major (13)  ·  Mania (13)  ·  Depressive Disorder (7)  ·  Depressive Disorder, Treatment-Resistant (5)  ·  Psychotic Disorders (5)  ·  Schizophrenia (4)  ·  Mood Disorders (3)  ·  Aggression (2)  ·  Alzheimer Disease (2)  ·  Brain Neoplasms (2)  ·  Conduct Disorder (2)  ·  Congenital Abnormalities (2)  ·  Leukemia, Myeloid, Acute (2)

Sponsors

AstraZeneca (7)  ·  New York State Psychiatric Institute (5)  ·  National Institute of Mental Health (NIMH) (4)  ·  Roxane Laboratories (4)  ·  State University of New York at Buffalo (4)  ·  University Hospitals Cleveland Medical Center (4)  ·  Shanghai Mental Health Center (3)  ·  University of Cincinnati (3)  ·  University of Sao Paulo (3)  ·  Dr. Inge Winter (2)  ·  Federal University of Rio Grande do Sul (2)  ·  Icahn School of Medicine at Mount Sinai (2)  ·  Indiana University (2)  ·  Melbourne Health (2)  ·  National Institute of Neurological Disorders and Stroke (NINDS) (2)

Countries

United States (69)  ·  Germany (9)  ·  Canada (6)  ·  China (6)  ·  France (6)  ·  Spain (6)  ·  Australia (5)  ·  Brazil (5)  ·  Denmark (5)  ·  Italy (5)  ·  Poland (5)  ·  Russia (5)  ·  South Africa (5)  ·  Bulgaria (4)  ·  Czechia (4)

Top investigators

Keming Gao, MD, PhD (4)  ·  Amit Anand, MD (3)  ·  James W Murrough, MD (2)  ·  Jerry Herron, MD (2)  ·  Marcelo Fleck, PhD (2)  ·  Trisha Suppes, MD, PhD (2)  ·  A Elias (1)  ·  A. John Rush, MD (1)  ·  Alan G. Mallinger, M.D. (1)  ·  Andree Daigneault, Dr. (1)  ·  Andrew A Nierenberg, MD (1)  ·  Anothony Cleare (1)

Results publications

PMID 18588360, PMID 23761037, PMID 28832750, PMID 34523118, PMID 35585125, PMID 39356507, PMID 41401709, PMID 11765093, PMID 15005752, PMID 15110730, PMID 15330403, PMID 15349007, PMID 15465989, PMID 15541061, PMID 15569893, PMID 15677618, PMID 15723025, PMID 15898966, PMID 15950022, PMID 15960566, PMID 16023735, PMID 16168792, PMID 16176440, PMID 16197928, PMID 16338761, PMID 16339615, PMID 16339616, PMID 16390886, PMID 16426088, PMID 16426099, PMID 16448626, PMID 16449473, PMID 16449474, PMID 16457894, PMID 16551710, PMID 16552982, PMID 16554525, PMID 16554526, PMID 16566612, PMID 16566627, PMID 16566901, PMID 16595351, PMID 16635643, PMID 16636629, PMID 16642436, PMID 16675760, PMID 16677228, PMID 16690084, PMID 16754414, PMID 16816220

NIH funding

2023 (2), 2008 (1), 2014 (1), N01MH080001 (1), P30MH086045 (1), R01AG047146 (1), R01MH050165 (1), R01MH059710 (1), R01MH060353 (1), R01MH060845 (1), R01MH061609 (1), R01MH063632 (1), R01MH069801 (1), R01MH075025 (1), R01MH078060 (1)